The latest report published by IMARC Group, titled “Veterinary Pain Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on veterinary pain management market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global veterinary pain management market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Veterinary pain management refers to the medical practice dedicated to alleviating and controlling pain and discomfort in animals. This field of veterinary medicine involves utilizing various medications, therapies, and techniques that target the underlying causes of pain, such as inflammation, injury, or surgical procedures. Veterinary pain management is essential to improve the quality of life for animals by reducing suffering and enabling quicker recovery from illness or surgery. Through a combination of pharmaceuticals such as analgesics and non-pharmaceutical therapies like acupuncture and physical rehabilitation, veterinarians are able to provide comprehensive care tailored to the specific needs of each animal. It is a vital component in veterinary practice, ensuring animal welfare and contributing to the overall success of treatments and interventions.
Request to Get the Sample Report: https://www.imarcgroup.com/veterinary-pain-management-market/requestsample
Market Trends:
The global market is primarily driven by the growing awareness about animal health and well-being, and the importance of pain management in veterinary care. Moreover, the significant rise in pet ownership and the willingness to invest in quality pet care are acting as vital growth-inducing factors for the market. Besides this, the growing demand for advanced, effective, and compassionate pain management due to rising societal concerns for animal welfare is creating lucrative opportunities in the market. Also, the development of new medications and therapeutic approaches is impacting the market positively. The market is further driven by favorable government support and regulatory guidelines ensuring quality animal care. Apart from this, the expansion of organized veterinary healthcare channels, both online and offline, is creating a positive outlook for the market.
View Full Report with TOC & List of Figure:
https://www.imarcgroup.com/veterinary-pain-management-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Assisi Animal Health
- Bayer AG
- Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
- Ceva Sante Animale
- Chanelle Pharma
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Idexx Laboratories Inc.
- Merck & Co. Inc.
- Norbrook
- Vetoquinol S.A.
- Zoetis Inc
Veterinary Pain Management Market Segmentation:
Our report has categorized the market based on region, product, animal type, application and end user.
Breakup by Product:
- Drugs
- NSAIDs
- Anesthetics
- Opioids
- Other Drugs
- Devices
- Laser Therapy
- Electromagnetic Therapy
Breakup by Animal Type:
- Companion
- Livestock
Breakup by Application:
- Osteoarthritis and Joint Pain
- Postoperative Pain
- Cancer
- Others
Breakup by End User:
- Hospitals and Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
